Literature DB >> 15699458

Stable 5,6-epoxyeicosatrienoic acid analog relaxes coronary arteries through potassium channel activation.

Wenqi Yang1, Kathryn M Gauthier, L Manmohan Reddy, Bhavani Sangras, Kamalesh K Sharma, Kasem Nithipatikom, John R Falck, William B Campbell.   

Abstract

5,6-epoxyeicosatrienoic acid (5,6-EET) is a cytochrome P450 epoxygenase metabolite of arachidonic acid that causes vasorelaxation. However, investigations of its role in biological systems have been limited by its chemical instability. We developed a stable agonist of 5,6-EET, 5-(pentadeca-3(Z),6(Z),9(Z)-trienyloxy)pentanoic acid (PTPA), in which the 5,6-epoxide was replaced with a 5-ether. PTPA obviates chemical and enzymatic hydrolysis. In bovine coronary artery rings precontracted with U46619, PTPA (1 nmol/L to 10 micromol/L) induced concentration-dependent relaxations, with maximal relaxation of 86+/-5% and EC50 of 1 micromol/L. The relaxations were inhibited by the cyclooxygenase inhibitor indomethacin (10 micromol/L; max relaxation 43+/-9%); the ATP-sensitive K+ channel inhibitor glybenclamide (10 micromol/L; max relaxation 49+/-6%); and the large conductance calcium-activated K+ channel inhibitor iberiotoxin (100 nmol/L; max relaxation 38+/-6%) and abolished by the combination of iberiotoxin with indomethacin or glybenclamide or increasing extracellular K+ to 20 mmol/L. Whole-cell outward K+ current was increased nearly 6-fold by PTPA (10 micromol/L), which was also blocked by iberiotoxin. Additionally, we synthesized 5-(pentadeca-6(Z),9(Z)-dienyloxy)pentanoic acid and 5-(pentadeca-3(Z),9(Z)-dienyloxy)pentanoic acid (PDPA), PTPA analogs that lack the 8,9 or 11,12 double bonds of arachidonic acid and therefore are not substrates for cyclooxygenase. The PDPAs caused concentration-dependent relaxations (max relaxations 46+/-13% and 52+/-7%, respectively; EC50 1micromol/L), which were not altered by glybenclamide but blocked by iberiotoxin. These studies suggested that PTPA induces relaxation through 2 mechanisms: (1) cyclooxygenase-dependent metabolism to 5-ether-containing prostaglandins that activate ATP-sensitive K+ channels and (2) activation of smooth muscle large conductance calcium-activated K+ channels. PDPAs only activate large conductance calcium-activated K+ channels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699458     DOI: 10.1161/01.HYP.0000153790.12735.f9

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Potassium channels and neurovascular coupling.

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Circ J       Date:  2010-03-16       Impact factor: 2.993

2.  Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.

Authors:  Brandon T Larsen; Hiroto Miura; Ossama A Hatoum; William B Campbell; Bruce D Hammock; Darryl C Zeldin; John R Falck; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-28       Impact factor: 4.733

Review 3.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

4.  14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.

Authors:  Ishfaq A Bukhari; Kathryn M Gauthier; Setti G Jagadeesh; Bhavani Sangras; J R Falck; William B Campbell
Journal:  J Pharmacol Exp Ther       Date:  2010-09-29       Impact factor: 4.030

Review 5.  Epoxyeicosatrienoic acid analogs and vascular function.

Authors:  V Sudhahar; S Shaw; J D Imig
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

6.  Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain.

Authors:  Tricia M Miller; Mark K Donnelly; Elizabeth A Crago; Dana M Roman; Paula R Sherwood; Michael B Horowitz; Samuel M Poloyac
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-10-14       Impact factor: 3.205

7.  14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.

Authors:  J R Falck; Ravinder Kodela; Rajkumar Manne; Krishnam Raju Atcha; Narender Puli; Narsimhaswamy Dubasi; Vijay L Manthati; Jorge H Capdevila; Xiu-Yu Yi; Daniel H Goldman; Christophe Morisseau; Bruce D Hammock; William B Campbell
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

8.  14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.

Authors:  John R Falck; Sreenivasulu Reddy Koduru; Seetaram Mohapatra; Rajkumar Manne; Krishnam Raju Atcha; Raju Atcha; Vijaya L Manthati; Jorge H Capdevila; Sarah Christian; John D Imig; William B Campbell
Journal:  J Med Chem       Date:  2014-08-19       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.